Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut mucosal surface and microbiota niche represent a complex biological interface between the host's intestinal epithelium and the diverse microbial community residing within the gut lumen (Belkaid & Hand, 2014). This niche is characterized by a protective mucus layer, primarily composed of mucin glycoproteins, which serves as both a physical barrier and a nutrient source for commensal bacteria (Turner, 2009). Biologically, it plays a critical role in maintaining homeostasis by facilitating nutrient absorption, educating the mucosal immune system, and preventing the colonization of pathogens through competitive exclusion (Bäckhed et al., 2005). Dysregulation of this environment, often termed dysbiosis or barrier dysfunction, is linked to numerous pathologies, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and metabolic disorders (Khoruts & Sadowsky, 2016). Therapeutic strategies targeting this niche aim to restore microbial balance and reinforce the mucosal barrier through the use of probiotics, prebiotics, and fecal microbiota transplants. Monitoring the health of this niche often involves assessing microbial diversity and measuring markers of intestinal permeability like zonulin or fecal calprotectin.
Modulation of microbial ecology, competitive inhibition of pathogens, and restoration of epithelial barrier integrity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut mucosal surface and microbiota niche.